Healthcare -
Biotechnology - NASDAQ - US
$ 8.33
18 %
$ 1.34 B
Market Cap
-3.82
P/E
NVAX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative NVAX - Novavax, Inc.
469 M
LAST VALUE
25.37%
2 YEAR CAGR
68.61%
5 YEAR CAGR
41.26%
10 YEAR CAGR